[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335732-105":59,"doc-detail-335732-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","peg-bct-100-and-canavanine-synergistically-induce-apoptosis-in-arginine-biosynthetic-enzyme-deficient-pancreatic-cancer","PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer","","Arginine deprivation via arginase is explored as a cancer therapy, particularly for tumors dependent on exogenous arginine. This study tests a combination of PEGylated recombinant human arginase (PEG-BCT-100) in clinical trials with the toxic arginine analog canavanine in pancreatic cancer. The pair shows a strong synergistic antitumor effect in vitro and in vivo, triggering apoptotic death in pancreatic cancer cells while sparing normal fibroblasts. Tumors deficient in ASS1 and OTC appear more susceptible, and the enzymes’ loss may serve as predictive biomarkers in other arginine-dependent cancers.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/peg-bct-100-and-canavanine-synergistically-induce-apoptosis-in-arginine-biosynthetic-enzyme-deficient-pancreatic-cancer/335732/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/peg-bct-100-and-canavanine-synergistically-induce-apoptosis-in-arginine-biosynthetic-enzyme-deficient-pancreatic-cancer/335732.png","ImageObject",300,407,{"name":92,"@type":93},"Theodora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What treatment combination is evaluated in this study?","Question",{"text":112,"@type":113},"The study evaluates PEGylated recombinant human arginase (PEG-BCT-100) together with canavanine in pancreatic cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What effects does the combination produce on cancer and normal cells?",{"text":117,"@type":113},"The combination induces apoptotic cell death in pancreatic cancer cells while normal fibroblast cells remain viable.",{"name":119,"@type":110,"acceptedAnswer":120},"Why are ASS1 and OTC deficiencies important for treatment response?",{"text":121,"@type":113},"Pancreatic tumors lacking the key arginine biosynthesis enzymes ASS1 and OTC are suggested to be more susceptible, and ASS1/OTC negativity may function as predictive biomarkers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335732,1790145895,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},687197207919,"https://ap-avatar.wpscdn.com/avatar/a000253d6f5f7c60be?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779446848396160552","RESEARCH ARTICLE  [https://doi.org/10.1158/2767-9764.CRC-24-0425](https://doi.org/10.1158/2767-9764.CRC-24-0425)  OPEN ACCESS  \nPEG-BCT-100 and Canavanine Synergistically  Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer  \nTsz Tung Kwong1, Hao Hao Deng1, Chi-Hang Wong1, Anthony W. H. Chan2, Landon Long Chan1, Siu-Ho K. Chok3, Paul N. Cheng4, and Stephen Chan1  \n􀀶  \nABSTRACT  \nArginine deprivation using arginase emerges as a potential cancer treatment approach, as some cancers have been found to be arginine-auxotrophic, relying on exogenous arginine for their growth. In this study, we evaluated the combination of a PEGylated recombinant human arginase (PEG-BCT-100), which is currently undergoing clinical trials, with a toxic arginine analog, canavanine, in pancreatic cancer. Remarkable synergistic antitumor effect was observed both in vitro and in vivo. Specifically, the combination treatment induced apoptotic cell death in pancreatic cancer cells, whereas normal fibroblast cells remained viable. Our findings also suggested that pancreatic tumors lacking the key enzymes in arginine biosynthesis, argininosuccinate synthetase 1 (ASS1) and ornithine transcarbamylase (OTC), were more susceptible to the treatment. From our in-house cohort and online database  \nanalysis, we found that the majority of the patients with pancreatic cancer exhibited deficiencies in both ASS1 and OTC enzymes, suggesting that the combination of arginine deprivation and canavanine could be particularly effective in these patients. The ASS1 and OTC negativity could also serve as predictive biomarkers for the response in other arginine-dependent cancers.  \nSignificance: This study investigates the synergistic antitumor effect of PEG-BCT-100, an arginase, in clinical trials, with canavanine in pancreatic cancer, in vitro and in vivo. The treatment induces cancer cell apoptosis while sparing normal fibroblasts. Our findings suggest heightened susceptibility of pancreatic tumors deficient in arginine biosynthesis enzymes ASS1 and OTC.  \nIntroduction  \nPancreatic cancer is the leading cause of cancer-related deaths in developed countries, with the lowest 5-year survival rate among all cancers at 12%(1, 2). More than 80% of cases are diagnosed at an advanced stage, either locally advanced or metastatic, rendering the tumors unresectable (3) . Currently, chemotherapy serves as the standard therapy for metastatic pancreatic cancer. Despite an increasing number of approved chemotherapy agents or regimens, the median overall survival for patients with metastatic pancreatic cancer remained less than 12 months (2, 4, 5) . Therefore, there is a pressing need for novel treatment alternatives for advanced pancreatic cancer.  \n1Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. 2Department of Anatomical and Cellular Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. 3Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China. 4BioCancer Treatment International Ltd, Hong Kong SAR, China.  \nCorresponding Author: Stephen Chan, Department of Clinical Oncology, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR 999077, China. E-mail: [chanlam_stephen@cuhk.edu.hk](chanlam_stephen@cuhk.edu.hk)  \n[doi:](doi: 10.1158/2767-9764)[ 10.1158/2767-9764](doi: 10.1158/2767-9764) .CRC-24-0425  \nThis open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.  \n©2024 The Authors; Published by the American Association for Cancer Research  \nArginine deprivation has emerged as a potential anticancer treatment due to thephysiologic vital role of arginine in cell growth and proliferation. Arginine, a semi-essential amino acid, serves as a precursor for the biosynthesis of various essential compounds, including proteins, polyamines, creatinine, and nitric ","cbCaivmIH6Yxc8PU","https://ap.wps.com/l/cbCaivmIH6Yxc8PU","pdf",9467274,"English","# Abstract\n# Significance\n# Introduction","[{\"question\":\"What treatment combination is evaluated in this study?\",\"answer\":\"The study evaluates PEGylated recombinant human arginase (PEG-BCT-100) together with canavanine in pancreatic cancer.\"},{\"question\":\"What effects does the combination produce on cancer and normal cells?\",\"answer\":\"The combination induces apoptotic cell death in pancreatic cancer cells while normal fibroblast cells remain viable.\"},{\"question\":\"Why are ASS1 and OTC deficiencies important for treatment response?\",\"answer\":\"Pancreatic tumors lacking the key arginine biosynthesis enzymes ASS1 and OTC are suggested to be more susceptible, and ASS1/OTC negativity may function as predictive biomarkers.\"}]","PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer | PDF",1790012143,25]